尿核基质蛋白22作为膀胱肿瘤标记物的临床评价
Clinical evaluating urinary nuclear matrix protein 22 taken as a marker of bladder tumnour
出处
《实用医药杂志》
2003年第1期73-75,共3页
Practical Journal of Medicine & Pharmacy
参考文献20
-
1Yang CH, Lambie EJ, Snyder M, et al. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol, 1992, 116(6): 1303
-
2Miller TE, Beausang LA, Winchell LF, et al. Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res, 1992, 52(2): 422
-
3Stampfer DS, Carpinito GA, Rodriguez VJ, et al. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol, 1998, 159(2): 394
-
4Sozen S, Biri H, Sinik Z, et al. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder. Eur Urol, 1999, 36(3): 225
-
5Chahal R, Darshane A, Browning A J, et al. Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder. Eur Urol, 2001, 40(4): 415
-
6Mian C, Lodde M, Haitel A, et al. Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder. Urology, 2000, 55(2): 223
-
7Oge O, Atsu N, Kendi S, et al. Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer. In Urol Nephrol, 2001, 32(3): 367
-
8Casella R, Huber P, Blochlinger A, et al. Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer. experience with 130 patients with biopsy confirmed tumor. J Urol, 2000, 164(6): 1926
-
9Lahme S, Bichler KH, Feil G, et al. Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer. Urol Int, 2001, 66(2): 72
-
10Saad A, Hanbury DC, Mcnicholas TA, et al. A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int, 2002, 89(4): 369
-
1虞颂庭,张景全.对免疫组织化学及流式细胞术测定膀胱肿瘤标记物之评价[J].中华泌尿外科杂志,1989,10(4):213-216.
-
2毕长富,张克荣,董浩,王占海,夏增学.尿脱落细胞CK20检测对膀胱癌诊断的意义[J].河北医药,2010,32(12):1537-1538. 被引量：1
-
3都卫国,靳风烁.膀胱肿瘤的新标记物[J].国外医学（泌尿系统分册）,1999,19(4):154-155. 被引量：2
-
4熊林,谭万龙.尿液中膀胱肿瘤标记物的研究进展[J].国外医学（泌尿系统分册）,2005,25(6):792-796.
-
5徐战平,戴宇平,赵继宗,邹伟民,王行环,杨浣情.膀胱移行细胞癌患者尿核基质蛋白22检测的意义[J].中华检验医学杂志,2005,28(2):192-192. 被引量：2
-
6孙光,左杰,张日强.膀胱癌患者尿NMP22测定的临床意义[J].中华泌尿外科杂志,2001,22(10):625-627. 被引量：6
-
7董忠,林雪琴.尿核基质蛋白22在膀胱移行细胞癌电切术后复发监测中的临床应用[J].中国现代药物应用,2009,3(14):58-59.
-
8徐春国,杨彬.膀胱肿瘤标记物的研究进展[J].医学与哲学（B）,2012,33(12):40-41. 被引量：5
-
9张芹,王惠民,马利民,张跃平.尿核基质蛋白22测定方法的评价及应用[J].临床检验杂志,2003,21(5):297-297. 被引量：1
-
10何朝宏,肖传国,杜茂信.尿核基质蛋白22在膀胱癌术后复发监测中的应用[J].临床泌尿外科杂志,2005,20(2):107-108. 被引量：3
